Ignite Creation Date:
2024-05-05 @ 4:56 PM
Last Modification Date:
2024-10-26 @ 9:26 AM
Study NCT ID:
NCT00354146
Status:
COMPLETED
Last Update Posted:
2011-02-01
First Post:
2006-07-18
Brief Title:
A Phase 2 Study of Farnesyl Transferase Inhibitor R115777 Tipifarnib in Patients With Refractory or Relapsed Acute Myeloid Leukemia
Sponsor:
Johnson Johnson Pharmaceutical Research Development LLC
Organization:
Johnson Johnson Pharmaceutical Research Development LLC